Stabilization of Octastatin®, a somatostatin analogue: Comparative accelerated stability studies of two formulations for freeze-dried products

Pharmaceutica Acta Helvetiae

Volumn 71, Issue 2, 1996, Pages 161-166

  Barthomeuf, C ^a   Pourrat, H ^a   Pourrat, A ^a   Ibrahim, H ^b   Cottier, P E ^b  

^a UNIVERSITÉ CLERMONT AUVERGNE   (France)

^b DEBIOPHARM SA   (Switzerland)

Author keywords

Accelerated stability study; HPLC; Octastatin; Somatostatin analogue; Stabilizing agent; Vapreotide

Indexed keywords

GLUTAMIC ACID; LACTOSE; VAPREOTIDE; ANTINEOPLASTIC AGENT; BUFFER; DRUG DERIVATIVE; SOMATOSTATIN;

ARTICLE; DRUG DETERMINATION; DRUG MANUFACTURE; DRUG STABILITY; FREEZE DRYING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMIDITY; NONHUMAN; REGRESSION ANALYSIS; ULTRAVIOLET SPECTROPHOTOMETRY; CHEMISTRY; COMPARATIVE STUDY;

ANTINEOPLASTIC AGENTS; BUFFERS; DRUG STABILITY; FREEZE DRYING; GLUTAMIC ACID; LACTOSE; SOMATOSTATIN;

EID: 0030176790     PISSN: 00316865     EISSN: None     Source Type: Journal    
DOI: 10.1016/0031-6865(95)00058-5     Document Type: Article

References (17)

1. Bringer, J., Hedt, A. and Grodsky, G.M. (1981) Prevention of insulin aggregation by dicarboxylic amino-acids during prolonged infusion. Diabetes 30, 83-85.
2. Cai, R.Z., Szoke, B., Fu, D., Redding, T.W. and Schally, A.V. (1986) Synthesis and biological activity of highly potents octapeptides analogs of somatostatin. Proc. Natl. Acad. Sci. USA, 83, 1896-1900.
3. Colaco, C.A.L.S., Smith, C.J.S., Sen, S., Roser, D.H., Newman, Y., Ring, S. and Roser, B.J. (1994) Chemistry of protein stabilisation by lactose, chapter 14, in Formulation and delivery of proteins and peptides. ACS Symposium series 567, American Chemical Society, Washington, DC.
4. Deghenghi, R. (1988) Somatostatin analogs in the treatment of carcinoid syndrome. Biomed. Pharmacother. 42, 585-588.
5. Girard, P.M., Goldsmidt, E., Vittecoq, D, Massip, P., Aeyohas, M.C., Bouslama, K., May, T., Gallais, H., Gastiaburu, J. and Schally, A.V. (1990) Preliminary results of vapreotide (a new somatostatin analogue) in AIDS related diarrhea. Paper presented at the 6th International Conference on AIDS, San Francisco, CA, 20-24 june.
6. Girard, P.M., Goldmidt, E., Vittecoq, D., Massip, P., Gastiaburu, J, Aeyohas, M.C., Coulaud, J.P. and Schally, A.V. (1992) Vapreotide, a somatostatin analogue, in cryptosporidiosis and other AIDS-related diarrhoeal diseases. AIDS 6, 715-718.
7. Jocelyn, P.C. (1972) Biochemistry of the SH Group, Academic Press, New York, pp. 118-126.
8. Lougheed, W.D., Albisser, A.M., Martindale, H.M., Chow, J.C. and Clement, J.R. (1983) Physical stability of insulin formulations. Diabetes 32, 124-127.
9. Morant, T., Kohn, S., Humbold, F. and Zobelli, H.I. (1990) Symptomatic, biochemical and radiological improvement of metastatic carcinoid traeted with RC-160, a novel somatostatin analogue. J. Suisse Cancer St. Gall, abstract 38, p. 42.
10. Pourrat, H., Barthomeuf, C., Pourrat., Cottier, P.E. and Ibrahim, H. (1995) Stabilization of Octastatin, a somatostatin analogue. Preparation of freeze-dried products for parenteral injection. Biol. Pharm. Bull. 18(5), 766-771.
11. Quinn, R. and Andradre, D. (1983) Minimizing the aggregation of neutral insulin solutions. J. Pharm. Sci. 72, 1472-1473.
12. Schally, A.V. (1988) Oncological applications of somatostatin analogs. Cancer Res. 48, 6977-6985.
13. Sethuraman, V., Burton, K.W., Mehta, R.C. and DeLuca, P.P. (1992) Stabilization of a somatostatin analogue in solution formulations. Paper presented at AAPS Annual meeting, November, San Antonio, TX.
14. Sethuraman, V. (1993) The phenomenon of particle formation and its inhibition in solution and solid formulations of a somatostatin analog. Ph.D. Thesis, University of Kentucky, KY.
15. Sethuraman, V. and DeLuca, P.P. (1994) Nature of interaction between an octapeptide and buffer ions. J. Pharm. Res. 11(10), S232.
16. The rules governing medicinal products in the European Community (1989) Publication Office of the European Community, Vol. II, Part II.
17. Williamson, M.B. (1970) Catalysis of formation of mixed disulfides between cystine and globulins by copper ions, Biochem. Biophys. Res. Commun. 39, 379-383.